N-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide

C100H96F3N15O9S — CID 159869396

IUPACN-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide
SMILESCC(=O)Nc1ccc2c(ccn2Cc2ccc(-c3ccn(C)n3)cc2)c1.CC(=O)Nc1ccc2c(ccn2Cc2ccc(-c3ccn[nH]3)cc2)c1.CC(=O)Nc1ccc2c(ccn2Cc2ccc(C3CCC(=O)N3)cc2)c1.CC(=O)Nc1ccc2c(ccn2Cc2ccc(COC(F)(F)F)cc2)c1.CC(=O)Nc1ccc2c(ccn2Cc2ccc(CS(C)(=O)=O)cc2)c1
InChIInChI=1S/C21H20N4O.C21H21N3O2.C20H18N4O.C19H17F3N2O2.C19H20N2O3S/c1-15(26)22-19-7-8-21-18(13-19)9-12-25(21)14-16-3-5-17(6-4-16)20-10-11-24(2)23-20;1-14(25)22-18-6-8-20-17(12-18)10-11-24(20)13-15-2-4-16(5-3-15)19-7-9-21(26)23-19;1-14(25)22-18-6-7-20-17(12-18)9-11-24(20)13-15-2-4-16(5-3-15)19-8-10-21-23-19;1-13(25)23-17-6-7-18-16(10-17)8-9-24(18)11-14-2-4-15(5-3-14)12-26-19(20,21)22;1-14(22)20-18-7-8-19-17(11-18)9-10-21(19)12-15-3-5-16(6-4-15)13-25(2,23)24/h3-13H,14H2,1-2H3,(H,22,26);2-6,8,10-12,19H,7,9,13H2,1H3,(H,22,25)(H,23,26);2-12H,13H2,1H3,(H,21,23)(H,22,25);2-10H,11-12H2,1H3,(H,23,25);3-11H,12-13H2,1-2H3,(H,20,22)
InChIKeyNSDJFCZQYLXCLI-UHFFFAOYSA-N
MW1741.02 g/mol
LogP19.56
Rot. Bonds22

About N-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide

N-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide (PubChem CID 159869396) has the molecular formula C100H96F3N15O9S and a molecular weight of 1741.02 g/mol. Its IUPAC name is N-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide.

Molecular Properties

Compound NameN-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide
PubChem CID159869396
Molecular FormulaC100H96F3N15O9S
Molecular Weight1741.02 g/mol
Exact Mass1739.72
IUPAC NameN-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide
SMILESCC(=O)Nc1ccc2c(ccn2Cc2ccc(-c3ccn(C)n3)cc2)c1.CC(=O)Nc1ccc2c(ccn2Cc2ccc(-c3ccn[nH]3)cc2)c1.CC(=O)Nc1ccc2c(ccn2Cc2ccc(C3CCC(=O)N3)cc2)c1.CC(=O)Nc1ccc2c(ccn2Cc2ccc(COC(F)(F)F)cc2)c1.CC(=O)Nc1ccc2c(ccn2Cc2ccc(CS(C)(=O)=O)cc2)c1
InChIInChI=1S/C21H20N4O.C21H21N3O2.C20H18N4O.C19H17F3N2O2.C19H20N2O3S/c1-15(26)22-19-7-8-21-18(13-19)9-12-25(21)14-16-3-5-17(6-4-16)20-10-11-24(2)23-20;1-14(25)22-18-6-8-20-17(12-18)10-11-24(20)13-15-2-4-16(5-3-15)19-7-9-21(26)23-19;1-14(25)22-18-6-7-20-17(12-18)9-11-24(20)13-15-2-4-16(5-3-15)19-8-10-21-23-19;1-13(25)23-17-6-7-18-16(10-17)8-9-24(18)11-14-2-4-15(5-3-14)12-26-19(20,21)22;1-14(22)20-18-7-8-19-17(11-18)9-10-21(19)12-15-3-5-16(6-4-15)13-25(2,23)24/h3-13H,14H2,1-2H3,(H,22,26);2-6,8,10-12,19H,7,9,13H2,1H3,(H,22,25)(H,23,26);2-12H,13H2,1H3,(H,21,23)(H,22,25);2-10H,11-12H2,1H3,(H,23,25);3-11H,12-13H2,1-2H3,(H,20,22)
InChIKeyNSDJFCZQYLXCLI-UHFFFAOYSA-N
XLogP19.56
TPSA289.12 Ų
H-Bond Donors7
H-Bond Acceptors17
Rotatable Bonds22
Heavy Atoms128
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001741.02
LogP ≤ 519.56
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1017

Analyze N-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide?
The IUPAC name of N-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide (CID 159869396) is N-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide.
What is the SMILES notation for N-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide?
The canonical SMILES for N-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide is CC(=O)Nc1ccc2c(ccn2Cc2ccc(-c3ccn(C)n3)cc2)c1.CC(=O)Nc1ccc2c(ccn2Cc2ccc(-c3ccn[nH]3)cc2)c1.CC(=O)Nc1ccc2c(ccn2Cc2ccc(C3CCC(=O)N3)cc2)c1.CC(=O)Nc1ccc2c(ccn2Cc2ccc(COC(F)(F)F)cc2)c1.CC(=O)Nc1ccc2c(ccn2Cc2ccc(CS(C)(=O)=O)cc2)c1.
What is the InChIKey of N-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide?
The InChIKey is NSDJFCZQYLXCLI-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H20N4O.C21H21N3O2.C20H18N4O.C19H17F3N2O2.C19H20N2O3S/c1-15(26)22-19-7-8-21-18(13-19)9-12-25(21)14-16-3-5-17(6-4-16)20-10-11-24(2)23-20;1-14(25)22-18-6-8-20-17(12-18)10-11-24(20)13-15-2-4-16(5-3-15)19-7-9-21(26)23-19;1-14(25)22-18-6-7-20-17(12-18)9-11-24(20)13-15-2-4-16(5-3-15)19-8-10-21-23-19;1-13(25)23-17-6-7-18-16(10-17)8-9-24(18)11-14-2-4-15(5-3-14)12-26-19(20,21)22;1-14(22)20-18-7-8-19-17(11-18)9-10-21(19)12-15-3-5-16(6-4-15)13-25(2,23)24/h3-13H,14H2,1-2H3,(H,22,26);2-6,8,10-12,19H,7,9,13H2,1H3,(H,22,25)(H,23,26);2-12H,13H2,1H3,(H,21,23)(H,22,25);2-10H,11-12H2,1H3,(H,23,25);3-11H,12-13H2,1-2H3,(H,20,22).
What are the key properties of N-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide?
N-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide has a molecular weight of 1741.02 g/mol, XLogP of 19.56, 22 rotatable bonds, 7 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(methylsulfonylmethyl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(5-oxopyrrolidin-2-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(1H-pyrazol-5-yl)phenyl]methyl]indol-5-yl]acetamide;N-[1-[[4-(trifluoromethoxymethyl)phenyl]methyl]indol-5-yl]acetamide is sourced from PubChem (CID 159869396), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).